Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Suspended 1 Not yet recruiting 1 No longer available 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 439 Carboplatin 322 Nivolumab 298 Cyclophosphamide 286 Specimen Handling 271 Magnetic Resonance Spectroscopy 259 Cisplatin 250 Paclitaxel 249 Radiotherapy 230 Dexamethasone 184 Biopsy 182 Gemcitabine 180 durvalumab 171 atezolizumab 152 Doxorubicin 141 Rituximab 138 Lenalidomide 136 Ipilimumab 134 Docetaxel 132 Bevacizumab 132 Radiation 121 Capecitabine 120 Oxaliplatin 116 Etoposide 116 Radiosurgery 113 Fluorouracil 112 Pemetrexed 109 fludarabine 106 venetoclax 102 Prednisone 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × taletrectinib × Clear all

NCT04919811 2026-01-07

TRUST-II

Nuvation Bio Inc.

Phase 2 Active not recruiting

217 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡